share_log

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

SEC ·  Nov 4 20:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more